---
format: 
  revealjs:
    margin: 0
    theme: theme.css
    embed-resources: true
editor: visual
fig-cap-location: top
slide-number: true
---

------------------------------------------------------------------------

![](images/title_background.png){.absolute top="0%" width="1000" height="450"}

![](images/wadoh_logo2.png){.absolute bottom="15%" width="30%"}

::: {style="position: absolute; bottom: 14%; left: 30%; font-size: 120%"}
**Selecting Bioinformatic Tools for Public Health**
:::

::: {style="position: absolute; bottom: 4%; left: 30%; font-size: 70%"}
Jared Johnson, PhD, MSc <br> April 8, 2025
:::

------------------------------------------------------------------------

## Selecting Bioinformatic Tools {background-color="#FFFFFF"}

::: {layout-ncol="2"}
::: fragment
![**Expectation**](images/expectation.png){fig-align="left"}
:::

::: fragment
![**Reality**](images/reality.png){fig-align="left"}
:::
:::

# Getting Started {background-color="#2FAFA1" style="color: white"}

## Things to know before you start {background-color="#FFFFFF"}

:::::::: columns
:::::: {.column width="50%" style="font-size: 60%;"}
::: fragment
**Why do you need the tool?**

-   What will be reported?

-   Who are you reporting to?
:::

::: fragment
**How will the tool be used?**

-   Clinical vs surveillance

-   Frequency of reporting
:::

::: fragment
**What resources do you have?**

-   Human resources (e.g., technical expertise)

-   Compute resources

-   Lab resources (e.g., sequencers)
:::
::::::

::: {.column width="50%"}
![](images/coffee.png)
:::
::::::::

## What will be reported? {background-color="#FFFFFF"}

![](images/clipboard-1396732557.png) ![](images/clipboard-4207363907.png){.absolute left="775" bottom="0"}

:::: {.relative style="font-size: 75%; width: 800px"}
::: incremental
-   Bioinformatic tools often have multiple functions / outputs

-   Clearly define what will be reported (e.g., AMR genes, phylogenetic tree, clade, etc.,)

-   Helps to avoid becoming overwhelmed or distracted
:::
::::

## Who are you reporting to? {background-color="#FFFFFF"}

![](images/customers.png){.absolute top="100" left="0"}

::: {.absolute style="bottom: 200px; left: 600px"}
-   Who will receive the results?

-   How will the result be used?
:::

## How will the results be used? {background-color="#FFFFFF"}

::::: columns
::: {.column width="50%" style="font-size: 80%;"}
**Clinical vs Surveillance**

-   May dictate accuracy and precision requirements

**Frequency of Reporting & Sample Size**

-   Important when considering available resources (memory, storage, time)
:::

::: {.column width="50%"}
![](images/weird_tree.png)
:::
:::::

## What resources do you have? {background-color="#FFFFFF"}

::::: columns
::: {.column width="50%"}
![](images/resources.png)
:::

::: {.column width="50%" style="font-size: 80%;"}
**Human Resources**

-   Expertise and bandwidth

**Compute Resources**

-   Available hardware and software

-   IT restrictions

**Lab Resources**

-   What data can the lab produce?
:::
:::::

# Start the search! üîç {background-color="#809658"}

## Places to start

:::: {.callout-note style="font-size: 95%; width: 500px; position: absolute; left: 0px" icon="false"}
### Institutions

![](images/cdc_logo.png){.absolute top="30%" left="5%" width="50"} ![](images/broad_logo.png){.absolute top="65%" left="5%" width="50"}

::: {style="margin-left: 75px;"}
**CDC** : MycoSNP, PHoeNIx, IRMA/MIRA<br><br>**Broad** : GATK, Terra, Cromwell, IGV, Picard, Pilon
:::
::::

:::: {.callout-warning style="font-size: 95%; width: 500px; position: absolute; left: 0px; bottom: 25px" icon="false"}
### Development Teams

![](images/nextstrain_logo.png){.absolute top="30%" left="5%" width="50"} ![](images/andersen_lab_logo.png){.absolute top="65%" left="5%" width="50"}

::: {style="margin-left: 75px; margin-bottom: 10px;"}
**Nextstrain** : Nextclade, Auspice, Augur<br><br>**Andersen Lab** : Freyja, iVar
:::
::::

:::: {.callout-tip style="font-size: 95%; width: 500px; position: absolute; left: 575px" icon="false"}
### State Labs

![](images/UTPHL_logo.png){.absolute top="30%" left="5%" width="50"} ![](images/WAPHL_logo.png){.absolute top="60%" left="5%" width="50"}

::: {style="margin-left: 75px; margin-bottom: 10px;"}
**UT PHL** : Cecrete<br><br>**WA PHL** : BigBacter, VAPER, EPITOME, RECAPP, pre_mycosnp
:::
::::

:::: {.callout-caution style="font-size: 95%; width: 500px; position: absolute; left: 575px; bottom: 25px" icon="false"}
### Developers

![](images/torsten.png){.absolute top="30%" left="5%" width="50"} ![](images/ryan.png){.absolute top="60%" left="5%" width="50"}

::: {style="margin-left: 75px;"}
**Torsten Seemann** : Prokka, Snippy, Shovill, Abricate, mlst<br><br>**Ryan Wick** : Unicycler, Bandage, Polypolish, Trycycler
:::
::::

## Theiagen Genomics

![](images/theiagen.png){fig-align="center"} [github.com/Theiagen](https://github.com/Theiagen)

## Community Resources

:::: {.callout-warning style="font-size: 100%" icon="false"}
### Slack Channels

![](images/slack_logo.png){.absolute top="28%" left="3%" width="100"}

::: {style="margin-left: 150px;"}
-   ¬µbioinfo (microbial-bioinfo.slack.com)
-   StaPH-B (staph-b-dev.slack.com)
-   SPHERES (cspheres.slack.com)
:::
::::

:::: {.callout-note style="font-size: 100%" icon="false"}
### State Public Health Bioinformatics Workgroup (StaPH-B)

![](images/staphb_logo.png){.absolute top="65%" left="3%" width="100"}

::: {style="margin-left: 150px;"}
-   github.com/StaPH-B/docker-builds
-   hub.docker.com/r/staphb
:::
::::

------------------------------------------------------------------------

![](images/clipboard-1252165566.png)

## If all else fails...

![](images/clipboard-1016134269.png)

## Finding tools with AI

::::: fragment
::: {.callout-important style="font-size: 70%; position: absolute; top: 15%; left: 0%; width: 300px" icon="false"}
### ChatGPT

![](images/clipboard-1267249376.png){width="300px" height="250px"}
:::

::: {style="position: absolute; bottom: 10%; left: 0%; width: 300px; text-align: center; font-size: 80%" icon="false"}
**8 tools**<br>(no links)<br>(long vs short)
:::
:::::

::::: fragment
::: {.callout-note style="font-size: 70%; position: absolute; top: 15%; left: 33%; width: 300px" icon="false"}
### Copilot

![](images/clipboard-3987164707.png){width="300px" height="250px"}
:::

::: {style="position: absolute; bottom: 10%; left: 33%; width: 300px; text-align: center; font-size: 80%" icon="false"}
**3 tools**<br>(with links)
:::
:::::

::::: fragment
::: {.callout-warning style="font-size: 70%; position: absolute; top: 15%; left: 66%; width: 300px" icon="false"}
### Gemini

![](images/clipboard-2845041476.png){width="300px" height="250px"}
:::

::: {style="position: absolute; bottom: 10%; left: 66%; width: 300px; text-align: center; font-size: 80%" icon="false"}
**1 tool**<br>(no links)
:::
:::::

# Make the Initial Selection {background-color="#932C71"}

## Tool Selection Criteria

::: {.absolute style="top: 20%; left: 0%; width: 500px; border-radius: 15px; background-color: rgba(147, 44, 113, 0.5); font-size: 60%; padding-left: 20px"}
**Essential Criteria**

-   [x] Produces Desired Result
-   [x] Compatible with Resources & Data
-   [x] Ensures Data Privacy & Securty
:::

::: {.absolute style="top: 50%; left: 0%; width: 500px; border-radius: 15px; background-color: rgba(47, 175, 161, 0.5); font-size: 60%; padding-left: 20px"}
**Ideal Criteria**

-   [ ] Established Track Record
-   [ ] Community / Industry Support
-   [ ] Peer-reviewed
-   [ ] Version Control
-   [ ] Comprehensive Documentation
-   [ ] Easy to Install & Use
:::

![](images/clipboard-2092400096.png){.absolute top="18%" left="55%" width="500px"}

## Don't Fear Deadware

::: {.fragment style="position: absolute; top: 15%; left: 0%; font-size: 60%; width: 440px; border-radius: 15px; background-color: rgba(110, 55, 138, 0.20); padding: 20px"}
**Deadware** - software or hardware that is no longer supported, maintained, or updated by its manufacturer.
:::

:::: fragment
![](images/clipboard-3698797198.png){.absolute top="40%" left="-5%" width="700"}

::: {style="position: absolute; top: 85%; left: 0%; font-size: 40%; width: 80px; border-radius: 15px; background-color: rgba(54, 145, 124, 0.20); padding-left: 10px; padding-right: 10px"}
[link to post](https://www.reddit.com/r/bioinformatics/comments/1joyd0p/the_star_aligner_is_unmaintained_now/?share_id=RSguhThZ_4CIxazuOUZZT&utm_content=2&utm_medium=ios_app&utm_name=ioscss&utm_source=share&utm_term=1&rdt=39440)
:::
::::

::: fragment
![](images/clipboard-2102826705.png){.absolute top="10%" left="50%" width="600"}
:::

::: {.fragment style="position: absolute; top: 17%; left: 54%; border-radius: 15px; background-color: rgba(47, 175, 161, 0.20); padding-bottom: 45px; padding-left: 550px"}
:::

::: {.fragment style="position: absolute; top: 41.5%; left: 56.5%; border-radius: 15px; background-color: rgba(245, 108, 66, 0.20); padding-bottom: 45px; padding-left: 500px"}
:::

::: {.fragment style="position: absolute; top: 63%; left: 59%; border-radius: 15px; background-color: rgba(47, 175, 161, 0.20); padding-bottom: 45px; padding-left: 480px"}
:::

::: fragment
![](images/clipboard-342408579.png){.absolute top="8%" left="17.5%"} ![](images/clipboard-346263517.png){.absolute top="18%" left="33%" width="75px"} ![](images/clipboard-337044349.png){.absolute top="21%" left="41%" width="75px"} ![](images/clipboard-421856104.png){.absolute top="23%" left="50%" width="75px"}
:::

## Group Activity: Downselection Criteria

::: {style="text-align: center; position: absolute; top: 40%; left: 15%"}
Work in groups to complete the activity:

[Click here](https://doh-jdj0303.github.io/binfx-hub/docs/presentations/2025/APHL_AMD_Days/tool_selection/amd_academy_tool_selection_ex1.html)
:::

## SPAdes (ChatGPT option)

![](images/clipboard-79929793.png){.absolute left="-100"}

::: {.absolute style="bottom: 150px; left: 775px; border-radius: 15px; background-color: rgba(47, 175, 161, 0.5); padding: 20px; font-size: 50%; width: 350px"}
**Ideal Criteria**

-   [ ] Established Track Record
-   [ ] Community / Industry Support
-   [ ] Peer-reviewed
-   [ ] Version Control
-   [ ] Comprehensive Documentation
-   [ ] Easy to Install & Use
:::

## AccuVIR (Copilot option)

![](images/clipboard-3020842991.png){.absolute left="-100"}

::: {.absolute style="bottom: 150px; left: 775px; border-radius: 15px; background-color: rgba(47, 175, 161, 0.5); padding: 20px; font-size: 50%; width: 350px"}
**Ideal Criteria**

-   [ ] Established Track Record
-   [ ] Community / Industry Support
-   [ ] Peer-reviewed
-   [ ] Version Control
-   [ ] Comprehensive Documentation
-   [ ] Easy to Install & Use
:::

## VIGA (Gemini option)

![](images/clipboard-3242895210.png){.absolute left="-100"}

::: {.absolute style="bottom: 150px; left: 775px; border-radius: 15px; background-color: rgba(47, 175, 161, 0.5); padding: 20px; font-size: 50%; width: 350px"}
**Ideal Criteria**

-   [ ] Established Track Record
-   [ ] Community / Industry Support
-   [ ] Peer-reviewed
-   [ ] Version Control
-   [ ] Comprehensive Documentation
-   [ ] Easy to Install & Use
:::

## Finding Tools with AI (Round 2)

![](images/clipboard-1780434154.png)

# Testing the tools {background-color="#286AB4"}

## Group Activity: Testing Viral Genome Assemblers

::: {style="text-align: center; position: absolute; top: 40%; left: 15%"}
Work in groups to complete the activity:

[Click here](https://doh-jdj0303.github.io/binfx-hub/docs/presentations/2025/APHL_AMD_Days/tool_selection/amd_academy_tool_selection_ex2.html)
:::

## Discussion: Testing Viral Genome Assemblers

:::::: {.callout-tip appearance="simple"}
## Questions

::: fragment
**Q1. Which assembler would you choose?**
:::

<br>

::: fragment
**Q2. What was your big take away from the activity?**
:::

<br>

::: fragment
**Q3. Would you add anything to the lists of "Ideal" or "Essential" criteria?**
:::

<br>
::::::
